Influenza Infection

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)

Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)

A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants

Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device

Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

Catechin Containing Mask for the Prevention of Influenza Infection

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer